Medtronic Receives FDA Breakthrough Device Designation for Developing Stent Graft System to Treat Thoracoabdominal Aortic AneurysmGlobeNewsWire • 10/08/19
Medtronic Initiates Worldwide Pivotal Study of a New Approach to Treating Dangerously Fast Heart RhythmsGlobeNewsWire • 10/07/19
Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI LeadsGlobeNewsWire • 10/07/19
Medtronic Announces Early Feasibility Trial for Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal ApproachGlobeNewsWire • 09/27/19
Resolute Onyx™ DES Meets Primary Endpoint in First-Ever Clinical Study Comparing Drug-Eluting Stents in High-Bleeding Risk (HBR) Patients with One-Month DAPTGlobeNewsWire • 09/26/19
Medtronic Surgical Synergy(SM) is Advanced with Range of New Procedural Solutions Unveiled at NASS 2019GlobeNewsWire • 09/24/19
Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis PatientsGlobeNewsWire • 09/23/19
MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended TargetsGlobeNewsWire • 09/18/19
Medtronic Introduces Envision™ Pro Continuous Glucose Monitoring (CGM) System in EuropeGlobeNewsWire • 09/17/19